Neurobiology of Aging
Volume 28, Issue 8 , Pages 1148-1162, August 2007

Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis

  • Honghui Chen

      Affiliations

    • Present address: Wuhan Psychiatric Hospital/Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
  • ,
  • Yunn-Chyn Tung
  • ,
  • Bin Li
  • ,
  • Khalid Iqbal
  • ,
  • Inge Grundke-Iqbal

      Affiliations

    • Corresponding Author InformationCorresponding author at: Neuroimmunology Laboratory, NYS Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314-6399, USA. Tel.: +1 718 494 5263; fax: +1 718 494 1080.

New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA

Received 7 July 2005; received in revised form 22 May 2006; accepted 24 May 2006. published online 21 July 2006.

Abstract 

The dentate gyrus of adult mammalian brain contains neural progenitor cells with self-renewal and multi-lineage potential. The lineage and maturation of the neural progenitors are determined by the composition and levels of the trophic factors in their microenvironment. In Alzheimer disease (AD) brain, especially the hippocampus, the level of basic fibroblast growth factor (FGF-2) is markedly elevated. Here we show that elevated FGF-2 enhances the division and nestin levels of cultured adult rat hippocampal progenitors but impairs neuronal lineage determination and maturation of these cells in culture. The trophic factors ciliary neurotrophic factor (CNTF), glial-derived neurotrophic factor (GDNF), and insulin-like growth factors-1 and -2 (IGF-1, IGF-2) as well as an Alzheimer peptidergic drug, Cerebrolysin® (CL), in which we found these neurotrophic activities, counteract the effect of FGF-2 in inducing neuronal lineage (early neurogenesis). Whereas CNTF is the most active of the neurotrophic factors studied in promoting neurogenesis, CL, probably because of a combined effect of these factors, induces similar changes but without inhibiting cell proliferation. These findings suggest that CNTF, GDNF, IGF-1, and IGF-2 are promising therapeutic targets for AD and other diseases in which neurogenesis is probably inhibited.

Keywords: Alzheimer disease, Cerebrolysin®, Progenitor cells, Neuronal differentiation, Neurogenesis, Neurotrophic factors, Ciliary neurotrophic factor, Glial-derived neurotrophic factor, Insulin-like growth factor-1, Insulin-like growth factor-2, Basic fibroblast growth factor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0197-4580(06)00188-6

doi:10.1016/j.neurobiolaging.2006.05.036

Neurobiology of Aging
Volume 28, Issue 8 , Pages 1148-1162, August 2007